Recent News and Articles on the Keywords: update + 0.26 + 2006  Related to the article below (Last Update: 8/5/2008)

WGL Holdings, Inc., Reports Third Quarter Fiscal Year 2008 ...
FOXBusiness -
We assume no obligation to update this guidance. The absence of any statement by us in the future should not be presumed to represent an affirmation of this ...WGL - KIDS
Idera Pharmaceuticals Reports Second Quarter 2008 Financial Results
MarketWatch - Aug 4, 2008
Idera disclaims any intention or obligation to update any forward-looking statements. Idera Pharmaceuticals, Inc. Condensed Statements of Operations ...IDRA - PINK:RCRS
London shares lower in early trade; BG falls despite earnings ...
Forbes, NY - Jul 24, 2008
The Dow Jones Industrial Average rose 29.88, or 0.26 percent, to 11632.38 after rising nearly 100 points early in the session. Broader stock indicators also ...OTC:BRGYY
Ore Reserve and Mineral Resource Update
MarketWatch - Jul 8, 2008
Serabi Mining plc ("Serabi" or the "Company") announces an update of mineral resources at its 100% owned Palito gold mine in Para state, northern Brazil and ...ASX:MIN - LON:SRB
Solar baseload update
Grist Magazine, WA - Jul 29, 2008
Here is the update by Jonathan G. Dorn: Note: The rest of this post is the EPI article. After emerging in 2006 from 15 years of hibernation, ...
Tercica Reports Second Quarter 2008 Financial Results
MarketWatch - Jul 30, 2008
Tercica disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release. ...TRCA - EPA:IPN
Manicouagan Provides Exploration Update
Market Wire (press release) - Jul 15, 2008
Sample 151082 consisting of 0.26 metres of core (42.64 metres to 42.90 metres down-hole) from DDH MCH 07-05 contains 1230 ppb (parts per billion) rhodium ...CVE:MAM
Pharmacopeia Announces Second Quarter 2008 Financial Results
MarketWatch - Jul 31, 2008
Pharmacopeia undertakes no obligation to (and expressly disclaims any such obligation to) publicly update or revise the statements made herein or the risk ...PCOP
Manson Creek Commences Field Program on Gillman Silver-Lead-Zinc ...
Market Wire (press release) - Jul 23, 2008
The northern sample assayed 5.96 g/t gold, 21.4 g/t silver, 0.29% lead, 0.26% zinc and 0.01% copper. The high grade Gillman mineral occurrence is a 0.3 to ...CVE:MCK - TSE:X
RightNow Technologies Announces Second Quarter 2008 Financial Results
Earthtimes (press release), UK - Jul 30, 2008
Net loss per share for the full year 2008 is expected to be in the range of $(0.30) to $(0.26) . Non-GAAP net loss per share, which excludes stock-based ...RNOW
Source: Google News

2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based … -
TJ Smith, J Khatcheressian, GH Lyman, H Ozer, JO … - Journal of Clinical Oncology, 2006 - jcojournal.org
... 2006 Update of Recommendations for the Use of White Blood Cell Growth ... 2005 update. ...
less infection-related mortality (3.1% versus 5.7%; OR = 0.51 [0.26-1.00]; P ...

Citicoline: Pharmacological and clinical review, 2006 update -
JJ Secades, JL Lorenzo - Methods Find Exp Clin Pharmacol, 2006 - journals.prous.com
... Citicoline: Pharmacological and Clinical Review, 2006 Update ... Citicoline:
Pharmacological and Clinical Review, 2006 Update 3 Page 4. ...

[PDF] The new sample of giant radio sources II. Update of optical counterparts, further spectroscopy of … -
J Machalski, M Jamrozy, S Zola, D Koziel - Arxiv preprint astro-ph/0605002, 2006 - arxiv.org
... ph/0605002 v1 28 Apr 2006 Astronomy & Astrophysics manuscript no. (will be inserted
by hand later) The new sample of giant radio sources II. Update of optical ...
-

The Swedish Twin Registry in the Third Millennium: An Update -
P Lichtenstein, PF Sullivan, S Cnattingius, M Gatz … - Twin Research and Human Genetics, 2006 - Aus Acad Press
... The Swedish Twin Registry in the Third Millennium: An Update ... 878 Twin Research and
Human Genetics December 2006 Paul Lichtenstein et al. ... 5.7% 2.8% 4.2% 0.26 ...

Inguinal Hernia Repair?Update 2006
A Fingerhut, B Millat, N Veyrie, E Chouillard, C … - Springer
... Inguinal Hernia Repair ? Update 2006 ... technique was better than the Lichtenstein
technique as concerned the incidence of wound infection (0.39 [0.26, 0.61]), he ...
-

[PDF] Historical Net Discount Rates?An Update Through 2006
TR Ireland - umsl.edu
Page 1. Draft Date 4/19/07 Historical Net Discount Rates?An Update Through 2006 ...
2006. ?Historical Net Discount Rates ? An Update through 2005. ...

[PDF] Chapman Lake Aquatic Vegetation Management Plan Update 2006 -
S Peel - indiana.gov
Page 1. Chapman Lake Aquatic Vegetation Management Plan Update 2006 Kosciusko
County, Indiana February 7, 2007 Prepared for: Chapman ...

[PDF] State-of-the-Art of High Power Gyro-Devices and Free Electron Masers Update 2006
F Karlsruhe, W Berichte - bibliothek.fzk.de
... High Power Gyro-Devices and Free Electron Masers Update 2006 M. Thumm ... High Power
Gyro-Devices and Free Electron Masers Update 2006 Manfred Thumm ...
-

Update in General Internal Medicine Knight and Fihn Ann Intern Med. 2006; 145: 52-61
CL Knight, SD Fihn - Am Coll Physicians
... Update in General Internal Medicine. ... 4 July 2006 | Volume 145 Issue 1 | Pages
52-61. ... The absolute risk reduction for ischemic stroke was 0.26% (number needed to ...

[PDF] Local Housing Strategy Update 2006
F Council - falkirk.gov.uk
O R A' Local Housing Strategy Update 2006 ... 1.4 In line with Communities Scotland?s
guidance on LHS Updates, this 2006 Update will also consider the following: ...

Source: Google Scholar
 

   
   

Clinical Trials Update: April 25, 2006

April 25, 2006 08:46:37 PM PST

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Hypertension (High Blood Pressure) and Diabetes - Type 2

The aim of this clinical research study is to investigate the effectiveness and safety of an investigational drug in lowering blood pressure in patients with diabetes and hypertension.

Volunteers for this study must be 18 or older, have a doctor's diagnosis of high blood pressure and type 1 or type 2 diabetes, and cannot have had a mini stroke in the past 12 months or a history of myocardial infarction.

Research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat85.html and http://www.centerwatch.com/patient/studies/cat603.html.

-----

Crohn's Disease

This study will investigate the effectiveness of Remicade (generic name infliximab) and Imuran (generic name azathioprine) in the treatment of patients with moderate-to-severe Crohn's disease.

Eligible candidates should be at least 18-years-old, have had Crohn's Disease for at least 6 weeks, and have no history of treatment with azathioprine, infliximab, 6-mercaptopurine or 6-thioguanine.

Additionally, patients may not have had intra-abdominal surgery within the past 6 months or weigh more than 140 kg (310 lbs).

Research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat51.html.

-----

Cutaneous Lupus Erythematosus

Volunteers between ages 18 and 60 with refractory cutaneous lupus erythematosus are needed to participate in a research study for a monoclonal antibody.

Patients who are generally in good health and must have been on a stable dose of any existing medications for 4 weeks may qualify. People with a history of HIV, tuberculosis, syphilis, hepatitis, spleen removal, severe allergic reactions, or alcohol or drug dependency or abuse will not be permitted to participate in this study.

The research site is in Louisville, Ky.

 

Continue with:

H2

H3

H4

H5

H6

H7

H8

H9

H9A

 

 © 2002-2006

Keywords:

Contact Iconocast

Home Page